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The purpose of our study is to identify and quantify the
association between high breast mass density and
breast malignancy using inductive logic programming
(ILP) and conditional probabilities, and validate this
association in an independent dataset. We ran our ILP
algorithm on 62,219 mammographic abnormalities. We
set the Aleph ILP system to generate 10,000 rules per
malignant finding with a recall 95% and precision 925%.
Aleph reported the best rule for each malignant finding.
A total of 80 unique rules were learned. A radiologist
reviewed all rules and identified potentially interesting
rules. High breast mass density appeared in 24% of the
learned rules. We confirmed each interesting rule by
calculating the probability of malignancy given each
mammographic descriptor. High mass density was the
fifth highest ranked predictor. To validate the associa-
tion between mass density and malignancy in an
independent dataset, we collected data from 180
consecutive breast biopsies performed between 2005
and 2007. We created a logistic model with benign or
malignant outcome as the dependent variable while
controlling for potentially confounding factors. We
calculated odds ratios based on dichomotized variables.
In our logistic regression model, the independent pre-
dictors high breast mass density (OR 6.6, CI 2.5–17.6),
irregular mass shape (OR 10.0, CI 3.4–29.5), spiculated
mass margin (OR 20.4, CI 1.9–222.8), and subject age
(β=0.09, pG0.0001) significantly predicted malig-
nancy. Both ILP and conditional probabilities show that
high breast mass density is an important adjunct
predictor of malignancy, and this association is con-
firmed in an independent data set of prospectively
collected mammographic findings.




he increasingly computerized nature of mod-
ern medicine creates vast amounts of bio-
medical data as a result of patient care. Large
amounts of data are generated in radiology not
only due to data-rich image files but because of
data available in structured imaging reports, such
as those utilized in breast imaging. In the past,
these repositories of data have been used to
generate novel hypotheses using data mining
techniques for knowledge discovery.
1–3 After
hypotheses have been generated, however, an
integral part of the knowledge discovery process
is evaluation of the discovered knowledge and its
application in healthcare.
4 One important aspect of
this evaluation is assessing the generalizability of
the results outside of the dataset that generated the
knowledge. Validating the findings of inductive
logic programming (ILP) within the domain of
breast imaging is the focus of this project.
ILP
5 is a computer programming technique that
is particularly helpful in aiding researchers in the
data mining and knowledge discovery process.
ILP's objective is to discover a set of if–then rules
that predict the presence or absence of a disease
state or outcome. Generating ILP rules requires:
(1) a series of positive and negative examples, (2)
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(3) user-defined constraints such as performance
parameters about what type of rules may be
learned. ILP has several advantages over proposi-
tional learning techniques such as logistic regres-
sion. First, it can utilize data from a relational
database with many tables, rather than a single
table. Second, the discovered rules, which are
based in logic, are easily understood by both
humans and computers. Finally, the rules can
provide insight about predictive indicators that
distinguish the negative examples from the pos-
itive examples.
One method to confirm the association between
a predictive indicator and a specific outcome is
probability theory.
6 Conditional probabilities
describe the probability of a specific outcome
given a set of indicators, for example the proba-
bility of malignancy given a finding on a mammo-
gram. Such probabilities provide insight into
indicators that are more or less predictive of a
specific outcome. By using ILP-generated rules in
conjunction with probability theory, we can iden-
tify and confirm novel indicators for later targeted
evaluation and application.
Breast imaging is a subspecialty area of radiol-
ogy ideally suited to hypothesis generation using
data mining techniques. First, there is a stand-
ardized lexicon, the Breast Imaging Reporting and
Data System (BI-RADS),
7 which is used by
radiologists when interpreting mammograms. BI-
RADS encourages radiologists to use specified
language to describe mammographic findings
(Fig. 1), which in turn can be used to generate
evidence-based recommendations. Research has
shown that BI-RADS descriptive terms can make
accurate and reliable predictions of breast can-
cer.
8–16 Second, many breast radiologists report
their findings on a structured report, using reporting
software. The databases behind these structured
reports can be queried for the mammographic
findings, and the data can be mined to generate
novel hypotheses.
The predictive capability of one BI-RADS
descriptor, the mammographic density of a mass,
remains controversial. Mammographic mass den-
sity is determined by comparing the density of the
mass to an equal volume of breast fibroglandular
tissue. The BI-RADS categories for mass density
are fat-containing, low density, equal (“iso”)
density, and high density (Fig. 1). For example,
if the mass is higher density (more white appearing
on the mammogram), it is recorded as “high
density.” In the past, experts have asserted, with
limited scientific data, that high-density masses are
more likely malignant. The only study reported in
the literature to evaluate the association between
breast mass density and cancer explicitly showed
that mass density is difficult to consistently
evaluate and that breast mass density contributes
less to predicting malignancy than traditionally
thought.
17 Since that research was performed in
the early 1990s, no studies in the literature have
evaluated the contribution of breast mass density
to the prediction of cancer. Recently, however,
research using ILP showed that high mass density
may indeed be an important predictor of cancer.
1
The purpose of this study is to confirm the
conclusions of this previous research using a
modified ILP method and probability theory, and
then to validate this conclusion by specifically
assessing the association between breast mass
density and pathologic outcome in an independent
dataset of mammographic findings.
MATERIALS AND METHODS
The Institutional Review Board of the Univer-
sity of Wisconsin School of Medicine and Public
Health approved and waived informed consent for
this study. The study fully complied with the
Health Insurance Portability and Accountability
Act.
Fig 1. BI-RADS descriptors.
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This study involved using a modified ILP
algorithm in conjunction with probability theory,
on a series of mammographic abnormalities linked
to the Wisconsin Cancer Reporting System, the
state's breast cancer registry. This exploratory
dataset has been described previously in the
literature,
1 but it is briefly described below for
the convenience of the reader.
Dataset of Positive and Negative Examples
Our series of positive and negative examples,
the exploratory dataset, utilized by the ILP
algorithm contains 48,744 mammograms from
18,270 patients performed at the Froedtert and
Medical College of Wisconsin Breast Imagining
Center between April 5, 1999, and February 9,
2004. All of the 62,219 mammographic abnormal-
ities were matched with the state cancer registry.
The dataset contains a total of 510 malignant and
61,709 benign abnormalities.
Background Knowledge
Background knowledge consists of all informa-
tion about the 62,219 abnormalities. The back-
ground knowledge for our exploratory dataset
contains descriptive indicators about the findings
on the mammogram, patient risk factors such as
age and family history, and the radiologist's BI-
RADS final assessment of each abnormality as
shown in Table 1. Each abnormality was inter-
preted by one of eight radiologists, two of which
were fellowship-trained, and the background
knowledge was collected by querying a mammog-
raphy structured reporting and tracking data
system (PenRad Technologies®, Minnetonka,
MN, USA). In addition, the background knowl-
edge for our analysis also included variables for
other findings on the same mammogram, and other
findings on the patient's previous mammograms.
User-defined Constraints
User-defined constraints limit the number and
type of rules that are generated by the ILP
algorithm. We limited the number of rules consid-
ered to 10,000 per malignant finding, and retained
rules that had a recall of at least 5% and a precision
of at least 25%. For the purposes of our study,
recall is defined as the fraction of truly malignant
abnormalities that a rule labels as malignant
(analogous to sensitivity). Precision is defined as
the fraction comprised of malignant abnormalities
that are accurately labeled as malignant by a rule
(analogous to positive predictive value).
Each rule is scored using the compression
scoring function,
18 defined as M–B–L, where M
is the number of malignant findings for which the
rule is true, B is the number of benign findings for
which the rule is true, and L is the number of
descriptors used in the rule. The best rule for each
abnormality is the one that optimizes this scoring
function. We limited the longest rule to a max-
imum of ten descriptors (L=10).
ILP Algorithm
Similarly to the technique reported previously,
1
we used Srinivasan's Aleph
18 ILP system to learn
rules from the set of examples. In this modified
ILP analysis, we set Aleph to consider rules for
each malignant finding in turn in the following
manner: The search through the space of rules
starts with the most general rule, based on
information from the background knowledge,
which is true for every mammographic finding
whether benign or malignant. For each round, the
best rule seen so far that meets the recall and
precision settings above is selected and extended.
Each descriptor from the selected finding is
considered as an extension by adding the descrip-
tor to the rule and calculating its score using the
compression scoring function. This process of
selecting the best rule seen so far and considering
all possible extensions repeats until 10,000 rules
have been considered for each malignant finding.
The single best rule for each malignant finding is
then reported. The algorithm was run on a single
desktop machine with an Intel® Xeon® 2.33-GHz
processor and 4 GB of RAM. The total time to run
the algorithm on our dataset was approximately
8h .
A total of 80 unique rules were learned that
met the above criteria. Of all the rules, each
rule was true, on average, for 40 malignant and
43 benign findings (precision of 48%) and
contained five descriptors. Combining all the
rules together, the entire set of 80 rules had a
recall of 67% and a precision of 23% in the
556 WOODS ET AL.dataset of 62,219 abnormalities. A radiologist
reviewed all 80 rules and identified potentially
interesting rules based on known significant
predictors of malignancy, such as spiculated
margins and older age, a few of which appear
in Table 2. Many of the descriptors used in the
rules are already known to be predictive of
malignancy. Similar to previous results, we
found that high breast mass density frequently
appeared in the set of rules. Of the 80 unique
rules learned, 19 (24%) contained the high mass
density descriptor.
Table 1. Exploratory Dataset Background Knowledge used for ILP
Patient descriptors Age
Hormone therapy
Personal history of breast cancer
Family history of breast cancer
Prior surgery





Stability (increasing, stable, or decreasing)
Calcification descriptors Shape
Distribution
Stability (increasing, stable, or decreasing)
Associated findings Skin thickening
Skin lesion
Trabecular thickening
Nipple retraction, skin retraction
Axillary adenopathy, lymph node
Architectural distortion
Special cases Tubular density
Asymmetric breast tissue
Focal asymmetric density
Additional background knowledge BI-RADS final assessment category
Reason for the mammogram (screening, diagnostic)
Other findings on the same mammogram
Other findings on a prior mammogram
Background knowledge based on the BI-RADS
7 lexicon. “Stability,” though not defined in the BI-RADS lexicon, is frequently used when
describing a mass or calcifications
Table 2. Exploratory Dataset Showing Examples of Rules Learned by ILP, Including Total, Benign, and Malignant Cases for which the
Rule is True
Rule Total Cases Benign (%) Malignant (%) Precision Recall
Finding is malignant if: 79 21 (26.6) 58 (73.4) 0.73 0.11
Mass margins = spiculated and
Mass density = high and
Reason for mammogram = diagnostic
Finding is malignant if: 66 29 (43.9) 37 (56.1) 0.56 0.07
Mass density = high and
Age 965 and
Mass size 910 mm and
Reason for mammogram = diagnostic
Finding is malignant if: 78 41 (52.6) 37 (47.4) 0.47 0.07
Mass density = high and
Personal history of breast cancer = yes and
Mass stability = increasing
Also shown are the precision and recall for each rule
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After discovering that high mass density fre-
quently appeared in rules learned by ILP, we
evaluated the predictive ability of each descriptor
alone and in comparison with other descriptors.
We calculated the conditional probability of
malignancy given each descriptor individually,
which is defined as the fraction of findings that
are both malignant and have the descriptor divided
by the total number of findings that have the
descriptor. Probabilities were smoothed using Lap-
lacian smoothing to help mitigate the problem of
rare descriptors. We then ordered the descriptors
from the most predictive to the least predictive.
The top ten descriptors with their associated
conditional probabilities are listed in Table 3. The
majority of the descriptors contained within rules
discovered by our ILP algorithm are already well-
established predictors of malignancy; however,
high mass density appears as the fifth most
predictive indicator.
Knowledge Discovery Conclusions
The ILP method generated several rules that
contained the high mass density descriptor, and
shows that high mass density is a useful
predictor of malignancy when used in conjunc-
tion with additional descriptors. Calculated
conditional probabilities further confirmed this
conclusion, demonstrating that high mass den-
sity is among the features most predictive of
malignancy.
Validation of Knowledge Discovery
Dataset
In order to validate the conclusions generated by
the data mining technique described above in an
independent dataset, we collected data from 706
consecutive breast biopsies of masses performed
between October 2005 and December 2007 at the
University of Wisconsin Hospitals and Clinics
Breast Center (a different medical center from the
dataset of abnormalities described above). All
female subjects who underwent image-guided core
biopsy (ultrasound, stereotactic, or MRI-guided)
for a solid, non-calcified mass seen on a diagnostic
mammogram in which the mass density was
described prospectively were eligible for this
study. There were 180 masses that met these
criteria. Each biopsy targeted a single mass.
Imaging and Evaluation
All mammographic studies were performed with
dedicated mammography equipment, on either
analog or digital machines. Of the 175 diagnostic
mammograms performed, there were 69 (39.4%)
analog mammographic examinations and 106
(60.6%) digital mammographic examinations. The
type of equipment was chosen by the technologist
based on availability. Eight interpreting radiologists
participated in this study, all of which practice in
the same academic group. Three of the radiologists
are fellowship-trained in breast imaging.
Each radiologist described the mass prospec-
tively as part of routine clinical practice at the time
Table 3. Exploratory Dataset Showing the Probability of Malignancy Given Individual Descriptors
Descriptor P(malignancy | descriptor) Benign Malignant
BI-RADS category = 5 0.62 109 181
Mass margin = spiculated 0.44 147 114
Regional pleomorphic calcifications 0.31 19 8
BI-RADS category = 4 0.28 403 160
Mass density = high 0.18 489 108
Mass shape = irregular 0.12 842 118
Nipple retraction = present 0.10 72 7
Mass size 930 mm 0.07 426 30
Clustered pleomorphic calcifications 0.07 937 67
Prior surgery = true 0.06 1,609 106
The ten descriptors with the highest probability of malignancy are shown. P(malignancy | descriptor) = the probability of malignancy
given the finding on the mammogram
558 WOODS ET AL.of imaging using the terminology of the fourth
edition of the BI-RADS lexicon.
7 Mass descriptors
were used at the discretion of the interpreting
radiologist and were entered directly into struc-
tured reporting software (PenRad Technologies®).
Each mass was given a final BI-RADS assessment
category by the interpreting radiologist.
Study End Points
After the mass was biopsied, a board-certified or
board-eligible pathologist evaluated each sample
to determine a final pathologic diagnosis. All
pathology results were correlated with mammo-
graphic findings at a weekly radiologic pathology
conference. Pathology results were grouped into
benign and malignant categories based on the
specific pathologic diagnosis. High-risk lesions,
such as atypia or radial scar, were considered
benign. For masses determined to be benign, we
matched each subject to a hospital-based cancer
registry and followed them for at least 12 months
(mean 25.5, range 12–38).
Statistical Analysis
We collected the data by querying the structured
reporting system for subject age, overall breast
composition, all mass descriptors (density, shape,
and margin), size of the mass, and image acquis-
ition technique (digital or analog). We entered
these data into a Microsoft Access Database and
performed all statistical analyses using R, version
2.8.1 (R Foundation for Statistical Computing,
Vienna, Austria). We grouped low and iso-dense
masses together since a small proportion of
the masses were considered low-density (16 of
180 masses, 8.9%). The log of the mass size was
used in all analyses to account for outliers. We
collapsed multi-level categorical variables (overall
breast composition, mass shape, and mass margin)
into dichotomous variables. For breast composi-
tion, the lower two categories (“almost entirely
fat” and “scattered fibroglandular densities”) were
compared to the higher two categories (“heteroge-
neously dense” and “extremely dense”). “Irregu-
lar” shape was compared to all other shape
descriptors, and “spiculated” margin was com-
pared to all other margin descriptors. Univariate
analysis was performed to test the association
between breast mass density, overall breast com-
position, image acquisition technique, age, and
size of the mass and the probability of benign or
malignant outcome. To account for multiple
masses in the same subject, we used linear
mixed-effect models to estimate p values, and
bootstrapping to calculate the odds ratio. A p value
of G0.05 was considered statistically significant for
all analyses.
Logistic Regression
In order to evaluate the relative contribution of
breast mass density to predicting malignancy while
controlling for potentially confounding known
predictors of malignancy, we created a logistic
linear mixed effects model with benign or malig-
nant outcome as the dependent variable. We used a
backward stepwise variable selection method and
determined the best fitting model based on the
Akaike Information Criterion (AIC) and deviance
differences. This type of model was used to
address clinically important predictors and remove
predictors from the model that did not improve
prediction accuracy. Independent variables entered
into the model included all collected variables
listed above in addition to the random effect
variable “interpreting radiologist.”
RESULTS
The study population included 180 masses that
were visualized on 175 diagnostic mammograms,
among 173 subjects. Of the 180 masses, there were
109 benign masses and 71 malignant masses.
Among the benign masses, 30 (27.5%) were
high-density, while among the malignant masses,
51 (71.8%) were high-density. The results of the
univariate analyses are presented in Table 4. Image
acquisition technique was the only variable among
those tested that was not found to be statistically
significant.
In our logistic regression model, the mass
descriptors high density (OR 6.6, CI 2.5–17.6),
irregular shape (OR 10.0, CI 3.4–29.5), and
spiculated margin (OR 20.4, CI 1.9–222.8) sig-
nificantly predicted malignancy (Table 5).
Although subject age (β=0.09, pG0.0001) also
significantly predicted malignancy, the other inde-
pendent variables tested did not improve predic-
tion accuracy and were removed from the model.
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In this study, we confirm the conclusions of
previous research by using ILP and calculated
conditional probabilities on a dataset of structured
mammographic findings. Both the ILP method and
conditional probabilities showed that high mass
density is a potentially important predictor of
breast malignancy. Most importantly, we validated
these conclusions in an independent dataset of
mammographic findings collected prospectively
during routine clinical practice.
One of the final steps in the knowledge discovery
process is the evaluation of hypotheses generated
using data mining techniques, which serves several
important roles, including determining if the
hypothesis is novel, medically important, and
generalizable outside of the mined dataset.
Although ILP has been used in the past
1 to show
that high mass density may be an important
predictor of malignancy, that research only raised
the possibility of the association but did not
quantify results or test the conclusion in an
independent dataset as we have done here. This
step is critical for both verifying that the association
is non-random or dataset-specific and proving its
generalizability. In order to use the results from data
mining techniques, validation analysis must be
conducted to provide convincing evidence of the
utility of the discovered knowledge.
The association between high mass density and
malignancy is interesting because, although experts
have asserted the association in the past,
19 it has not
been proven in the literature. The only study to
evaluate this association concluded that the contri-
bution of mass density to predicting malignancy
was less than previously thought. Our study, which
is larger and performed in a sample of consecutive
biopsies collected prospectively, showed that mass
density is an important adjunct descriptor that can
be used to help stratify the risk of malignancy.
The conclusions of this study are clinically
important for several reasons. First, in the setting of
mammography,identifyingnovel predictorsofbreast
cancer is important as the positive predictive value
(PPV) of biopsy remains quite low (10–35%). By
identifying additional features that aid in the diag-
nosis of cancer, we may be able to improve the PPV
ofbiopsy.Second,ourresearchshowstheimportance
of clinical structured reporting and the collection of
structured data. These data can be mined for the
purpose of knowledge discovery and used for
Table 5. Logistic Regression Model Results
Predictor β Coefficient Std. Error p Value Estimated OR (95% CI)
Mass density High 1.88 0.5 0.0002 6.6 (2.5–17.6)
Iso/low –– –1.0 (ref)
Mass shape Irregular 2.3 0.6 G0.0001 10.0 (3.4–29.5)
All others –– –1.0 (ref)
Mass margin Spiculated 3.01 1.22 0.01 20.4 (1.9–222.8)
All others –– –1.0 (ref)
(ref) signifies the reference level in the odds ratio calculation
Table 4. Univariate Analysis Results
Predictor Total Benign (%) Benign Mean Malignant (%) Malignant Mean p Value OR (95% CI)
Mass density High 81 30 (37) 51 (63) G0.0001 6.7 (3.5–13.9)
Iso/low 99 79 (79.8) 20 (20.2) 1.0 (ref)
Overall breast
composition
Lower density breasts 94 47 (50) 47 (50) 0.0003 2.6 (1.4–5.3)
Higher density breasts 86 62 (72.1) 24 (27.9) 1.0 (ref)
Image acquisition
Digital 109 70 (64.2) 39 (35.8) 0.2345 0.7 (0.4–1.3)
Analog 71 39 (54.9) 32 (45.1) 1.0 (ref)
Age 180 49.7 62.8 G0.0001 –
Size 180 13.3 15.9 0.023 –
(ref) signifies the reference level in the odds ratio calculation. (–) signifies that odds ratios could not be calculated on continuous
variables. Lower density breasts = “almost entirely fat” and “scattered fibroglandular densities.” Higher density breasts =
“heterogeneously dense” and “extremely dense” breasts
560 WOODS ET AL.validation of discovered hypotheses. Finally, our
study shows that we can take advantage of the
computer's ability to survey large amounts of data to
generate hypotheses, as well as the human's expertise
in evaluating those hypotheses.
There were limitations to our study. First,
although the datasets used in our study were from
different institutions, they were collected in the
same geographic region, thus making these datasets
possibly more homogeneous than datasets from
distinct geographic regions. Second, our method
relies on the input of a radiologist to determine the
importance of generatedrules.Inthe future, wemay
be able to further automate the rule selection
process using metrics, which would promote effi-
cient rule selection. In this way, techniques such as
ILP may help identify future research areas. For
example, mammography data that include biopsy
results could help determine the pathophysiologic
factors that link high mass density with malignancy,
which may lead to improvements in diagnosis and
treatment. Still, we believe the results of this study
are valid, and important conclusions can be drawn
from this line of research.
CONCLUSION
The results of our study show that ILP with
validation can be reliably used to help identify novel
hypotheses in the large amounts of biomedical data
available within the imaging enterprise. This kind of
research is important to the future of imaging
research, particularly in breast imaging, where the
amount of available data becomes increasingly vast
with the accelerating use of both ultrasound and
magnetic resonance imaging. By using data mining
techniques combined with targeted studies to vali-
date hypotheses, we may improve the efficiency of
discovering valuable medical knowledge.
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